Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

Take Heart in the Age of “Omics”

Radwan Abu-Issa, Margaret L. Kirby
Download PDF
https://doi.org/10.1161/01.RES.0000141017.99175.dd
Circulation Research. 2004;95:335-336
Originally published August 19, 2004
Radwan Abu-Issa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret L. Kirby
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics

Jump to

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
Loading
  • transcriptome
  • heart development
  • heart progenitors and stem cells

The advent of access to comprehensive sets of information (ie, genome, transcriptome, proteome, interactome, phenome, and localizome) has brought a new way of global thinking to biological questions, and analysis using these sets is increasingly the choice for many investigations. Although these approaches may appear as a substitute for the more traditional “reductionist” approach that tackles 1 or few genes or gene products at 1 time, they are, in reality, complementary and have the potential to greatly enhance the traditional approach. The “omic,” or comprehensive, approach can yield mountains of new information in a relatively short time. Progress in applying the “omic” approach is still in its early exponential phase and does not look like it will plateau any time soon.

An “omic” approach has now been used in the study of heart development. The results provide additional insights into the complexity and number of molecules that orchestrate the development and maintenance of multiple cell types and intricate physiology and pathology of the heart. Transcriptome, or expression profiling of certain cells, groups of cells, or tissues at defined stages and conditions, has been one of the earliest strategies applied to study of the heart. However, using the transcriptome as a tool has several pitfalls that must be acknowledged, including false-negatives and false-positives, frequently ascribed to problems with technical reproducibility. Transcriptome analysis also carries conceptual weaknesses, in that altered expression is not always causally related to a phenotype or process because a change in transcription may not necessarily register as a change in protein synthesis. Furthermore, gene regulation is not achieved only at the transcriptional level. Several other strategies such as posttranscriptional, translational, or posttranslational modifications may also play significant roles. Thus, several approaches are needed for more accurate conclusions.

Microarrays, or microchips, were first used to analyze the transcriptional profile of adult heart in normal and pathological conditions (reviewed by Cook and Rosenzweig)1 such as hypertrophy,2,3 cardiac infarction,4 and heart failure.5,6 Cell lines that can be induced to differentiate into cardiomyocytes have also provided valuable information.7 More recently, microarray analysis has also been extended to the study of heart development.8

The article by Masino et al, presented in this issue of Circulation Research,9 has taken advantage of transgenic technology to specifically mark and then isolate presumptive myocardial cells for transcriptome analysis at different stages of induction and differentiation. To identify myocardial cells specifically, the authors made a mouse expressing enhanced yellow fluorescent protein under control of a cardiac-specific enhancer constructed from the Nkx2.5 promoter region. This enhancer of Nkx2.5 is expressed in myocardial progenitor cells starting from the crescent stage (E7.75) and remains active in both the heart tube (E8.5) and looped heart tube (E9.5) stages. Although the Nkx2.5 enhancer does not necessarily identify all of the myocardial progenitors, it certainly provides access to a reasonably representative group.

Masino et al isolated enhanced yellow fluorescent protein-positive myocardial cells at the 3 stages mentioned using fluorescence-activated cell sorting with >95% purity. This approach has the advantage of restricting transcriptome analysis to a relatively pure cell type without mixing cells that usually contaminate myocardial preparations (ie, blood and endothelial cells).

The RNA isolated from selected cells was amplified using a T7-based system and hybridized to Affymetrics GeneChips. Analyses showed several hundred genes were enriched in the myocardial cells (≥2-fold) compared with age-matched, non-cardiac embryonic cells. The expression profile included many genes known to be important in myocardial development, confirming the validity of this approach.

Comparison of the enriched genes at the 3 stages analyzed showed strong overlap (>40%) between heart tube and looped heart stages, but <5% genes were enriched with the crescent stage. These results indicate that there are many specific genes that are involved in early heart development that await more detailed molecular and functional analysis.

An unexpected finding showed a set of genes known to be important in the hematopoietic/vascular program were strongly enriched at the heart crescent stage. These results support the idea of a common history of the two lineages and explain their ability to switch between these 2 cell fates, seen both in cell lines10 and in vivo (reviewed by Olson).11 The authors further compared the expression profile of the early developing myocardium with 2 different cell types: embryonic stem cells and adult mouse cardiomyocytes. Cardiac regulators and structural genes were enriched when compared with embryonic stem cells, as expected, and unchanged, or even reduced, when compared with adult mouse cardiomyocytes. Such comparisons facilitate understanding the behavior of potential myocardial stem cell populations. A detailed knowledge of the expression profile of heart precursors can establish criteria for the selection of stem cells for transplantation and reduce the possibility of unwanted fates that a stem cell population may undertake.

Masino et al substantiated the microarray data using RT-PCR and in situ hybridization. Several of the candidate genes were confirmed to be expressed at the right stages and in the right cells.

The task now is to best apply these new comprehensive approaches to understand the heart. Additional “transcriptomic” and other “omic” analyses will further advance heart research. For example, different early heart markers can be helpful to verify the available data, add other perhaps non-Nkx2.5 expressing myocardial populations, and ultimately complete the picture of early myocardial gene expression. Protein profiling (proteome) of the heart, more comprehensive analysis of gene function by knocking down or out of candidate genes (phenome), protein-protein interaction (interactome), and protein cellular and subcellular localization (localizome) are all needed for a deeper understanding of the development, physiology, and pathology of the heart. Each technique will collectively contribute to the diagnosis, prevention, and therapy of the great number of heart diseases.

Acknowledgments

We thank Melissa Colbert and Tony Creazzo for helpful discussions and comments on this editorial.

Footnotes

  • The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.

References

  1. ↵
    Cook SA, Rosenzweig A. DNA microarrays: implications for cardiovascular medicine. Circ Res. 2002; 91: 559–564.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Friddle CJ, Koga T, Rubin EM, Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci U S A. 2000; 97: 6745–6750.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Hwang DM, Dempsey AA, Lee CY, Liew CC. Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics. 2000; 66: 1–14.
    OpenUrlCrossRefPubMed
  4. ↵
    Stanton LW, Garrard LJ, Damm D, Garrick BL, Lam A, Kapoun AM, Zheng Q, Protter AA, Schreiner GF, White RT. Altered patterns of gene expression in response to myocardial infarction. Circ Res. 2000; 86: 939–945.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, Hawthorn L, Mitchell CA, Young JB, Francis GS, McCarthy PM, Bond M. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation. 2000; 102: 3046–3052.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Barrans JD, Stamatiou D, Liew C. Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. Biochem Biophys Res Commun. 2001; 280: 964–969.
    OpenUrlCrossRefPubMed
  7. ↵
    Anisimov SV, Tarasov KV, Riordon D, Wobus AM, Boheler KR. SAGE identification of differentiation responsive genes in P19 embryonic cells induced to form cardiomyocytes in vitro. Mech Dev. 2002: 117: 25–74.
    OpenUrlCrossRefPubMed
  8. ↵
    Afrakhte M, Schultheiss TM. Construction and analysis of a subtracted library and microarray of cDNAs expressed specifically in chicken heart progenitor cells. Dev Dyn. 2004; 230: 290–298.
    OpenUrlCrossRefPubMed
  9. ↵
    Masino AM, Gallardo TD, Wilcox CA, Olson EN, Sanders RW, Garry DJ. Transcriptional regulation of cardiac progenitor cell populations. Circ Res. 2004; 95: 389–397.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Eisenberg CA, Bader DM. Establishment of the mesodermal cell line QCE-6. A model system for cardiac cell differentiation. Circ Res. 1996; 78: 205–216.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Olson EN. The path to the heart and the road not taken. Science. 2001; 291: 2327–2328.
    OpenUrlFREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
August 20, 2004, Volume 95, Issue 4
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Take Heart in the Age of “Omics”
    Radwan Abu-Issa and Margaret L. Kirby
    Circulation Research. 2004;95:335-336, originally published August 19, 2004
    https://doi.org/10.1161/01.RES.0000141017.99175.dd

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Take Heart in the Age of “Omics”
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    Take Heart in the Age of “Omics”
    Radwan Abu-Issa and Margaret L. Kirby
    Circulation Research. 2004;95:335-336, originally published August 19, 2004
    https://doi.org/10.1161/01.RES.0000141017.99175.dd
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured